Medical devices, diagnostics and medtech

As well as our extensive legal knowledge, our lawyers have deep industry knowledge and provide pragmatic and commercially focused advice. The team includes former scientists and in-house lawyers.

• Advising on a large number of fundraisings for a number of device, diagnostic and digital health clients.
• Providing strategic HR support to a fast growing medical device business.
• Advising IQ Capital on its follow on investment in Fluidic Analytics, as part of a £21million fundraising.
• Advising German medical devices business TRACOE Medical GmbH on its acquisition of medical devices designer and distributor, Kapitex Healthcare Limited.
• Advising ground-breaking artificial intelligence business DeepMind Technologies on its Series A, B and C funding rounds, raising in aggregate £42million from a syndicate of investors including a large San Francisco-based VC and a number of Silicon Valley angel investors.
• Acting for a UK-based diagnostics company on a major cross-jurisdictional project providing regulatory advice across over 10 EU jurisdictions. The advice concerns the impact of the in vitro diagnostic regulations.
• Advising Prior Scientific on its acquisition of the Queensgate Nano business from Electron Technology. Prior Scientific is a global leader in the design and manufacture of optical systems with operations in Cambridge, the US, Germany, Japan and China.
• Advising Health Data Research UK on scale up activity.

Our clients include:

• Global organisations
• Fast growing companies in a wide range of therapeutic areas
• Universities involved in world-renowned research
• Leading research institutes
• Major research charities
• Government organisations
• Sector fund managers

We take our role within the industry seriously and offer advice through our Life Science Law blog, our Sequence Newsletter and our twitter feed @MRSequencelaw. 

We also contribute to Mills & Reeve's technology and GDPR articles. 

For the latest in-depth views on the legal implications of Brexit, visit our Brexit pages.